Efficacy and Safety of Pien Tze Huang Capsules in Patients with Herpes Zoster: A Multicenter, Randomized, Double-Blinded, and Placebo-Controlled Trial
Wenfeng Wu,Dingquan Yang,Daoshun Sui,Minghua Zhu,Guangpu Luo,Zhonghui Yang,Yongfeng Wang,Hong Luo,Li Ling,Zexin Zhang,Yanmei Wu,Guoming Feng,Hongyi Li
DOI: https://doi.org/10.1016/j.phymed.2024.155453
IF: 6.656
2024-01-01
Phytomedicine
Abstract:Background: Herpes zoster (HZ) is a common medical condition accompanied by several distressing symptoms, including acute pain. Pien Tze Huang (PZH) is a well-known traditional Chinese medicine (TCM) with numerous pharmacological effects, including antiviral properties, neuroprotection, and immunity regulation. Purpose: To investigate the efficacy and safety of PZH capsules in patients with HZ. Study design: A multicenter, double-blinded, randomized, and placebo-controlled trial from 8 hospitals in 5 cities of China. Methods: Eligible participants were randomly assigned to the PZH capsule and placebo group at a 1:1 ratio. Treatment was conducted for 14 days with a window period of no more than 2 days. For the first 7 days, participants received antiviral drugs combined with PZH capsules (0.6 g/time, 3 times a day) or placebos. For the remaining 7 days, they were only treated with PZH capsules (0.6 g/time, 3 times a day) or placebos. Results: We included 222 patients in the full analysis set (FAS), and 187 patients in the per protocol set (PPS). The change of numeric rating scale pain scores from baseline to the seventh day (+/- 1 day) after treatment in the PZH capsule group was statistically superior to the placebo group (FAS: 2.33 vs. 1.71, 97.5%CI: 0.03 - 1.19; PPS: 2.29 vs. 1.51, 97.5%CI: 0.18 - 1.38). In the PPS, there was a significant difference in the time (days) of pain relief between the placebo group and the PZH capsule group (Mean (SD): 5.71 (3.76) vs. 4.69 (3.57), p = 0.046). On the seventh day (+/- 1 day) after treatment, the level of CD8+ cells in the PZH capsule group were higher than those of the placebo group (FAS: Mean (SD): 24.08 (6.81) vs. 21.93 (8.19), p = 0.007; PPS: Mean (SD): 24.26 (6.93) vs. 22.15 (8.51), p = 0.012). The level of cytotoxic lymphocyte cells found similar results on the seventh day (+/- 1 day) (FAS: Mean (SD): 12.17 (4.65) vs. 10.55 (4.15), p = 0.018; PPS: Mean (SD): 12.25 (4.65) vs. 10.11 (3.93), p = 0.002). No serious adverse events were noted and PZH capsules were well tolerated. Conclusion: PZH capsules confer therapeutic effects on HZ with the TCM symptom of stagnated heat of liver channel by substantially reducing the pain intensity, shortening the time of pain relief as well as regulating the immune function. On the basis of the efficacy and safety profiles, PZH capsules may be a promising complementary therapy for the treatment of HZ.